ARS Pharmaceuticals (SPRY) Accounts payable

annual accounts payable:

$9.87M+$9.11M(+1200.40%)
December 31, 2024

Summary

  • As of today (June 25, 2025), SPRY annual accounts payable is $9.87 million, with the most recent change of +$9.11 million (+1200.40%) on December 31, 2024.
  • During the last 3 years, SPRY annual accounts payable has risen by +$8.08 million (+452.63%).
  • SPRY annual accounts payable is now at all-time high.

Performance

SPRY Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

quarterly accounts payable:

$4.09M-$5.78M(-58.51%)
March 31, 2025

Summary

  • As of today (June 25, 2025), SPRY quarterly accounts payable is $4.09 million, with the most recent change of -$5.78 million (-58.51%) on March 31, 2025.
  • Over the past year, SPRY quarterly accounts payable has increased by +$3.26 million (+388.08%).
  • SPRY quarterly accounts payable is now -58.51% below its all-time high of $9.87 million, reached on December 31, 2024.

Performance

SPRY quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

SPRY Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1200.4%+388.1%
3 y3 years+452.6%-
5 y5 years+709.7%+129.3%

SPRY Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1200.4%-58.5%+439.5%
5 y5-yearat high+1200.4%-58.5%+439.5%
alltimeall timeat high+1200.4%-58.5%+439.5%

SPRY Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$4.09M(-58.5%)
Dec 2024
$9.87M(+1200.4%)
$9.87M(+19.3%)
Sep 2024
-
$8.28M(+152.9%)
Jun 2024
-
$3.27M(+290.0%)
Mar 2024
-
$839.00K(+10.5%)
Dec 2023
$759.00K
$759.00K(-74.4%)
Sep 2023
-
$2.97M(+97.6%)
DateAnnualQuarterly
Jun 2023
-
$1.50M(-41.8%)
Mar 2023
-
$2.58M(+55.5%)
Dec 2022
$1.66M(-7.1%)
$1.66M(-14.4%)
Jun 2022
-
$1.94M(+8.5%)
Dec 2021
$1.79M(+46.5%)
-
Dec 2021
-
$1.79M
Dec 2020
$1.22M
-

FAQ

  • What is ARS Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual accounts payable year-on-year change?
  • What is ARS Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly accounts payable year-on-year change?

What is ARS Pharmaceuticals annual accounts payable?

The current annual accounts payable of SPRY is $9.87M

What is the all time high annual accounts payable for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual accounts payable is $9.87M

What is ARS Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, SPRY annual accounts payable has changed by +$9.11M (+1200.40%)

What is ARS Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of SPRY is $4.09M

What is the all time high quarterly accounts payable for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly accounts payable is $9.87M

What is ARS Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, SPRY quarterly accounts payable has changed by +$3.26M (+388.08%)
On this page